We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 81-100 of 10,000 results
  1. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation

    There is concern regarding the impact of selective serotonin reuptake inhibitors (SSRIs) on suicidal behaviour. Using the target trial framework, we...

    Tyra Lagerberg, Anthony A. Matthews, ... Zheng Chang in Neuropsychopharmacology
    Article Open access 28 July 2023
  2. Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study

    Background

    Prescription medications such as selective serotonin reuptake inhibitors (SSRIs), commonly used to treat depression, are associated with...

    Maria L. Ricardo-Silgado, Sneha Singh, ... Andres Acosta in BMC Medicine
    Article Open access 26 July 2022
  3. Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitors

    Drug-induced injury to the gastrointestinal tract has gained growing significance in recent years, and the list of causative medications keeps...

    Ana I. Varelas, Stefan Fürst, Cord Langner in Virchows Archiv
    Article Open access 02 June 2022
  4. Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals

    Brain serotonergic (5-HT) signaling is posited to modulate neural responses to emotional stimuli. Dysfunction in 5-HT signaling is implicated in...

    Anjali Sankar, Brice Ozenne, ... Patrick M. Fisher in Translational Psychiatry
    Article Open access 11 May 2023
  5. The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review

    Brain imaging techniques enable the visualization of serotonin transporter (SERT) occupancy as a measure of the proportion of SERT blocked by an...

    Anders Sørensen, Henricus G. Ruhé, Klaus Munkholm in Molecular Psychiatry
    Article Open access 21 September 2021
  6. Ventral prefrontal serotonin 1A receptor binding: a neural marker of vulnerability for mood disorder and suicidal behavior?

    Mood disorders and suicidal behavior have moderate heritability and are associated with altered corticolimbic serotonin 1A receptor (5-HT 1A ) brain...

    Spiro P. Pantazatos, Nadine M. Melhem, ... J. John Mann in Molecular Psychiatry
    Article 27 June 2022
  7. Molecular signature of excessive female aggression: study of stressed mice with genetic inactivation of neuronal serotonin synthesis

    Aggression is a complex social behavior, critically involving brain serotonin (5-HT) function. The neurobiology of female aggression remains elusive,...

    Tatyana Strekalova, Oleg Moskvin, ... Lee Wei Lim in Journal of Neural Transmission
    Article Open access 05 August 2023
  8. Serotonin transporter availability increases in patients recovering from a depressive episode

    Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy...

    Jonas E. Svensson, Cecilia Svanborg, ... Johan Lundberg in Translational Psychiatry
    Article Open access 10 May 2021
  9. The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices

    Background

    Bleedings are frequent and dreaded complications in heart failure patients with ventricular assist devices (VAD). Serotonin reuptake...

    Bianca Auschra, Markus J. Wilhelm, ... Lena Jellestad in BMC Cardiovascular Disorders
    Article Open access 22 March 2022
  10. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors

    Objective

    To evaluate the severity of neonatal opioid withdrawal syndrome (NOWS) in infants prenatally exposed to medications for opioid use disorder...

    Ludmila N. Bakhireva, Aydan Sparks, ... Amy Salisbury in Pediatric Research
    Article 29 September 2021
  11. Measurement of changes in endogenous serotonin level by positron emission tomography with [18F]altanserin

    Objective

    Positron emission tomography (PET) has been used to investigate changes in the concentration of endogenous neurotransmitters. Recently, this...

    Yoko Ikoma, Hiroyuki Takuwa, ... Tetsuya Suhara in Annals of Nuclear Medicine
    Article 08 June 2021
  12. Insulin modulates emotional behavior through a serotonin-dependent mechanism

    Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD)....

    Hugo Martin, Sébastien Bullich, ... Xavier Fioramonti in Molecular Psychiatry
    Article 07 October 2022
  13. Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report

    Background

    Over-the-counter medication overdose is a difficult diagnostic challenge for many physicians as common drug screening assays cannot detect...

    Roudi Bachar, John Robert Majewski, ... Anthony El-Khoury in Journal of Medical Case Reports
    Article Open access 04 November 2021
  14. Impact of chosen cutoff on response rate differences between selective serotonin reuptake inhibitors and placebo

    Response defined as a 50% reduction in the sum score of the Hamilton Depression Rating Scale (HDRS-17-sum) is often used to assess the efficacy of...

    Alexander Lisinski, Fredrik Hieronymus, ... Elias Eriksson in Translational Psychiatry
    Article Open access 14 April 2022
  15. Tryptophan and serotonin levels as potent biomarkers in diabetes mellitus complications: a new approach of diagnostic role

    Objective

    Alterations in the serotonergic system were verified to act a role in the pathogenesis of altered neurological and psychiatric diseases. In...

    Kamyar Khoshnevisan, Maryam Chehrehgosha, ... Amir Mohammad Meftah in Journal of Diabetes & Metabolic Disorders
    Article 18 July 2022
  16. Sudden infant death syndrome revisited: serotonin transporter gene, polymorphisms and promoter methylation

    Background

    Based on findings in the brain stems of SIDS victims, the serotonin transporter (5-HTT) gene has been discussed to be associated with SIDS.

    ...
    Nina Pfisterer, Fiona Meyer-Bockenkamp, ... Michael Klintschar in Pediatric Research
    Article Open access 11 November 2021
  17. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1

    Background

    Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer and associated with poor prognosis and shorter survival due to...

    Venhar Cınar, Zuhal Hamurcu, ... Bulent Ozpolat in Breast Cancer
    Article 25 August 2022
Did you find what you were looking for? Share feedback.